CONFERENCE COMMITTEE REP. NO. 71

 

Honolulu, Hawaii

                 , 2011

 

RE:    H.B. No. 484

       S.D. 2

       C.D. 1

 

 

 

Honorable Calvin K.Y. Say

Speaker, House of Representatives

Twenty-Sixth State Legislature

Regular Session of 2011

State of Hawaii

 

Honorable Shan S. Tsutsui

President of the Senate

Twenty-Sixth State Legislature

Regular Session of 2011

State of Hawaii

 

Sirs:

 

     Your Committee on Conference on the disagreeing vote of the House of Representatives to the amendments proposed by the Senate in H.B. No. 484, S.D. 2, entitled:

 

"A BILL FOR AN ACT RELATING TO ADVANCED PRACTICE REGISTERED NURSES,"

 

having met, and after full and free discussion, has agreed to recommend and does recommend to the respective Houses the final passage of this bill in an amended form.

 

     The purpose of this bill is to help ensure that advanced practice registered nurses are used to their full potential by:

 

     (1)  Requiring each hospital in the State to allow licensed advanced practice registered nurses to practice within the full scope of their authorized practice, including as primary care providers;

 

     (2)  Removing statutory provisions governing prescriptive authority for qualified advanced practice registered nurses that require the:

 

          (A)  State Board of Nursing (Board) to determine an exclusionary formulary for qualified advanced practice registered nurses with prescriptive authority;

 

          (B)  Department of Commerce and Consumer Affairs (DCCA) to establish a Joint Formulary Advisory Committee that shall recommend the applicable formulary for qualified advanced practice registered nurses to the Board; and

 

          (C)  Board to adopt rules reflecting an appropriate working relationship between a qualified advanced practice registered nurse and a licensed physician;

 

          and

 

     (3)  Authorizing qualified advanced practice registered nurses with prescriptive authority to request, receive, and dispense manufacturers' samples of over the counter and non‑controlled legend drugs.

 

     Your Committee on Conference has amended this bill by:

 

     (1)  Reinserting statutory provisions governing prescriptive authority for qualified advanced practice registered nurses that require the:

 

          (A)  Board to determine an exclusionary formulary for qualified advanced practice registered nurses with prescriptive authority; and

 

          (B)  DCCA to establish a Joint Formulary Advisory Committee that shall recommend the applicable formulary for qualified advanced practice registered nurses to the Board;

          and

 

     (2)  Making technical, nonsubstantive amendments for clarity, consistency, and style.

 


     As affirmed by the record of votes of the managers of your Committee on Conference that is attached to this report, your Committee on Conference is in accord with the intent and purpose of H.B. No. 484, S.D. 2, as amended herein, and recommends that it pass Final Reading in the form attached hereto as H.B. No. 484, S.D. 2, C.D. 1.

 

Respectfully submitted on behalf of the managers:

 

ON THE PART OF THE SENATE

 

ON THE PART OF THE HOUSE

 

____________________________

JOSH GREEN, M.D., Chair

 

____________________________

RYAN I. YAMANE, Co-Chair

____________________________

ROSALYN H. BAKER, Co-Chair

 

____________________________

ROBERT N. HERKES, Co-Chair